Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA [NA]
This clinical trial update describes a mobile health-enabled program to empower community health workers and adapt strategies to improve TB …
-
FDA approval · 2026-01-27FDA Approved: PRIFTIN — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for PRIFTIN (rifapentine) from Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Precision Rifampin Trial for Personalized Dosing [Phase 1]
A Phase 1 clinical trial from the University of Virginia is evaluating precision, personalized dosing of rifampin for tuberculosis and is cu…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008
A substudy of the CoVPN 3008 trial evaluating post-trial tuberculosis case finding has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Immunization With BCG Vaccine to Prevent Tuberculosis Infection [Phase 3]
Phase 3 trial evaluating Bacillus Calmette-Guérin (BCG) vaccine to prevent tuberculosis infection was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Candidate Clinical Correlate of Prognostic Outcome for TB Study
The University of California, San Francisco is recruiting a study to identify candidate clinical correlates that predict prognostic outcomes…
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Therapeutic Drug Monitoring for Linezolid in the Treatment of Rifampin-resistant Tuberculosis [NA]
Clinical trial evaluating therapeutic drug monitoring of Linezolid for rifampin-resistant tuberculosis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Pediatric Optimal Tuberculosis Treatment Evaluation and Reassessment
Clinical trial update for pediatric tuberculosis treatment evaluation and reassessment. The study is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Tuberculosis - Learning the Impact of Nutrition [NA]
A completed clinical trial from Boston Medical Center studying the impact of nutrition on tuberculosis, including considerations of malnutri…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis [Phase 3]
Phase 3 clinical trial update evaluating steroids and broad-spectrum antibiotics for the treatment of refractory sepsis in Africa. Tuberculo…
-
EMA withdrawal · 2026-01-05EMA Withdrawn: Granupas (previously Para-aminosalicylic acid Lucane) (para-aminosalicylic acid) — Eurocept International B. V.
The EMA has withdrawn Granupas, a para-aminosalicylic acid product, from the European market for tuberculosis treatment. The decision date i…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa [NA]
The update reports the completion of clinical trial NCT06214910 (ThiPhiSA) evaluating new pathways to prevention through community TB screen…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Evaluation of New TB Diagnostic Tests (NATs) in Pakistan [NA]
This update reports on an ongoing Mercy Corps Pakistan trial evaluating new tuberculosis diagnostic tests (NATs) in Pakistan, with enrollmen…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Digital Health Intervention to Improve TPT Uptake [NA]
A clinical trial update describes a digital health intervention aimed at improving uptake of tuberculosis preventive therapy in pulmonary tu…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Effectiveness of Computer-Aided Detection Chest X-Ray Screening for Improving Tuberculosis Diagnostic Yield in Chinese Primary Health Care Settings: Study Protocol for a Prospective Cluster Randomized Controlled Trial [NA]
This study protocol describes a cluster randomized trial to assess whether computer-aided detection on chest X-rays improves tuberculosis di…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Questioning the Epidemiology of Asymptomatic TB
Clinical trial update describing a study on the epidemiology of asymptomatic tuberculosis, currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Window Prophylaxis for Pediatric Tuberculosis Prevention Trial [NA]
Trial update announcing ongoing recruitment for a pediatric window prophylaxis study to prevent tuberculosis in household contacts.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Safety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in Healthy Volunteers [Phase 1]
Phase 1 trial evaluating safety and immune responses of two investigational RNA-based vaccines against tuberculosis in healthy volunteers ha…
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression [Phase 3]
A Phase 3 trial evaluating an adequate tuberculosis regimen in hospitalized HIV-infected patients with severe immune suppression has complet…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: TB YOUTH - TB sYstemic Management Using One-month, Ultra-short TPT Regimen for scHool Contacts [Phase 3]
A Phase 3 trial evaluating a one-month ultra-short preventive therapy regimen for school contacts to manage latent tuberculosis infection.
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention [Phase 1]
Phase 1 study from Stanford evaluating point-of-care pharmacogenomic testing to tailor isoniazid dosing for tuberculosis prevention; study c…
-
CLINICAL_TRIALS withdrawal · 2025-12-17Clinical Trial Update: Safety and Challenge Study of BCG TICE(R) Vaccination to Test Tuberculosis Immunity in Heathy Humans [Phase 1]
A Phase 1 safety/challenge study of the BCG TICE Bacillus Calmette-Guérin vaccine for testing tuberculosis immunity in healthy adults has be…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Diagnostic Utility of Mycobacterium Tuberculosis Cell-free DNA in Hong Kong
Clinical trial evaluating the diagnostic utility of Mycobacterium tuberculosis cell-free DNA in pleural tuberculosis and pleural biopsy samp…
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing safety, tolerability, and pharmacokinetics of isoniazid and rifapentine regimens (1 month daily or 3 mont…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients [Phase 4]
Phase 4 clinical trial update comparing daily rifapentine plus isoniazid for 1 month (1HP) versus weekly high-dose rifapentine plus isoniazi…